middle.news
Bio-Gene Raises $2.1M to Advance Flavocide® Approval and Product Scale-Up
9:48am on Monday 5th of May, 2025 AEST
•
Agriculture
Read Story
Bio-Gene Raises $2.1M to Advance Flavocide® Approval and Product Scale-Up
9:48am on Monday 5th of May, 2025 AEST
Key Points
Raised $2.1 million via a two-tranche placement at 2.3 cents per share
Share Purchase Plan offers eligible Australian shareholders up to $15,000 in shares at placement price
Funds earmarked for Flavocide® regulatory safety studies and Qcide scale-up
Second tranche and attaching options subject to shareholder approval at EGM by 14 July 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bio-Gene Technology (ASX:BGT)
OPEN ARTICLE